Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

This can be an important add-on to echocardiography in patients with a borderline need for intervention, researchers say.

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The multidisciplinary care required to treat these complex patients is most often found in higher-volume centers.